Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth

Tod White Promoted to President; Justin McAnear Appointed Chief Financial Officer FREMONT, Calif. -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced key additions to its executive leadership team. These appointments reflect the company's continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The [...]

Capital Markets Day 2025: Ready for the Next Wave of Growth

Merck KGaA, Darmstadt, Germany, is well-positioned for the next wave of growth following strategic portfolio streamlining and targeted investments. Strong position in attractive growth markets due to focused high-tech portfolio and targeted investments Process Solutions, the new Rare Diseases portfolio and Semiconductor Solutions to drive up to 80% of future growth Company targets mid-term annual [...]

Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation

Waltham, MA -- We are proud to announce that Advanced Instruments and Nova Biomedical are now officially doing business under a single, unified brand. This is a transformative moment in our journey to deliver greater value to customers across the biopharmaceutical and clinical markets. Starting today we will be also unveiling a refreshed brand identity [...]

Genomics launches Mystra: the world’s first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development

The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights and, therefore, the probability of honing in on successful drug candidates BOSTON -- Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare tools [...]

Lexogen Launches miRVEL Profiling Small RNA-Seq Kit for Streamlined and Cost-Efficient sRNA Expression Analysis

Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit, designed to facilitate small RNA research. The innovative kit integrates seamlessly in the miRVEL small RNA sequencing line and helps scientists achieve reliable results faster and with less hands-on work. The miRVEL Profiling [...]

Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025

OXFORD, England -- At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis. The team will highlight the unique capabilities of the PromethION in delivering comprehensive whole [...]

​Analytik Jena Launches 21 CFR Part 11 Compliance Module for qPCR Instruments

​Jena / Germany – Analytik Jena has expanded its qPCRsoft 6.0 software for the qTOWER iris with an optional module for 21 CFR Part 11 compliance. This enhancement ensures the software now meets the requirements of the U.S. FDA regulation for electronic records and signatures — a crucial step for laboratories operating in regulated environments such as [...]

Thermo Fisher Scientific Launches Enhanced Vanquish LC Systems with Torque-Controlled Fittings and First-Ever Platinum ACT™ Sustainability Ecolabel

WALTHAM, MA. Overview:   Thermo Fisher Scientific announces significant enhancements to its Vanquish™ HPLC and UHPLC systems, designed to deliver smarter usability, greater sustainability and improved lab productivity with liquid chromatography (LC) separations. The upgraded systems are the only systems to feature torque-controlled Thermo Scientific™ Viper™ TQ UHPLC fittings and are the first LC systems to [...]

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map variants SAN DIEGO  -- Illumina, Inc. (NASDAQ: ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read technology, evaluating its performance on regions [...]

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the 5-base genome for accelerating resolution of rare disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today [...]

Access IBO on Knowledge Center